STOCK TITAN

Gold River Prod SEC Filings

GRPS OTC Link

Welcome to our dedicated page for Gold River Prod SEC filings (Ticker: GRPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Trans American Aquaculture, Inc. (GRPS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as it develops its shrimp aquaculture and broodstock business. Filings identify the registrant as Trans American Aquaculture, Inc., a Colorado corporation, and document its efforts to function as a public company while pursuing sustainable shrimp production.

Investors can review periodic reporting activity, including notifications such as the NT 10-Q, where the company explains delays in filing a quarterly report due to ongoing review processes with its auditor. These filings help readers understand the timing and status of the company’s financial reporting as it works toward full SEC reporting standards described in its press releases.

The filings also detail capital-raising and financing arrangements. An 8-K describes a Securities Purchase Agreement with GHS Investments LLC for the sale of Series D Preferred Stock and the issuance of warrants to purchase common stock, relying on an exemption from registration under Regulation D. The same 8-K outlines a Consulting Agreement with Redhawk Investment Group, LLC for strategic advice and consulting services, with compensation in cash or preferred stock. These documents provide insight into how the company structures financing and advisory relationships.

Through Stock Titan, users can see GRPS filings as they are posted to EDGAR and use AI-powered summaries to interpret key sections, such as descriptions of preferred stock terms, warrant coverage, and consulting fee structures. The filings page is a resource for examining how Trans American Aquaculture reports material agreements, securities issuances, and reporting status updates, complementing the company’s press releases about its shrimp operations and sustainability focus.

Rhea-AI Summary

Trans American Aquaculture, Inc. reported continued operating losses and no shrimp revenue in its quarter ended September 30, 2025. For the three months, revenue was $0 and the net loss was $171,642, improving from a loss of $575,325 a year earlier mainly due to lower cost of goods sold and reduced legal, professional, and payroll expenses. For the nine months, revenue was also $0 versus $315,145 in 2024, with the net loss narrowing to $489,387 from $1,143,656.

The balance sheet shows a strained financial position, with current liabilities of $4,719,609 and current assets of $340,123, creating a working capital deficit of $4,379,486 and a stockholders’ deficit of $3,758,603. Cash was just $509 at quarter-end, and shareholders have loaned about $1,646,636 at double‑digit interest rates. The company exited Chapter 11 bankruptcy in October 2025 but still faces going concern uncertainty and is relying on GHS Investments equity financing and preferred stock and warrant issuances to fund operations. Common shares outstanding were 1,805,926,955 as of January 14, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Trans American Aquaculture, Inc. (GRPS) filed a Form 12b-25, notifying a late filing of its Form 10-Q for the period ended September 30, 2025. The company cites that it has been unable to complete the review process with its auditor.

Form 12b-25 is a standard notice used when a registrant cannot meet a filing deadline. The narrative identifies the audit review as the cause of delay, without additional financial details.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Trans American Aquaculture, Inc. filed Amendment No. 1 to its Q2 2025 Form 10‑Q to revise the Balance Sheet and Statements of Stockholders’ Equity, reconciling the common stock issued value to the appropriate prior quarter and making a minor reclassification to a preferred stock to be issued line; it also furnishes XBRL Exhibit 101. No other changes to the original report.

Operations remain limited: Q2 2025 revenue was $0 (vs. $5,019 in Q2 2024) and net loss was $204,038. For the six months ended June 30, 2025, revenue was $0 (vs. $315,145 in 2024) and net loss was $317,745 (vs. $568,332). Cash was $198 at June 30, 2025, with current assets of $303,323 and current liabilities of $4,654,029, a working capital deficit of $4,350,706. Shares outstanding were 1,805,926,955 as of October 9, 2025.

The company discloses a going concern uncertainty and a voluntary Chapter 11 filing in December 2024, with a plan confirmation hearing scheduled for August 18, 2025. Management also reports a material weakness in internal control over financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

Trans American Aquaculture (GRPS) filed its quarterly report, highlighting continued operating losses and liquidity stress. The company reported $0 revenue for both the three and six months ended June 30, 2025, with net losses of $204,038 and $317,745, respectively. Cash was $198 at quarter‑end, and current liabilities exceeded current assets by $4,350,706, indicating a significant working capital deficit.

The company remains under Chapter 11 protection following a December 2024 filing, with a plan confirmation hearing scheduled for August 18, 2025. Operations are paused; the company is maintaining broodstock only. Inventory totaled $302,409, primarily broodstock. Interest expense fell year over year, aiding a narrower loss.

To access funding, the company continued using preferred stock and warrant issuances with GHS, and it also disclosed an equity financing agreement that permits periodic common stock “puts.” Shares outstanding were 1,805,926,955 as of October 9, 2025. Management disclosed a going concern uncertainty and material weakness in internal control over financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Trans American Aquaculture, Inc. entered into a financing agreement with GHS Investments LLC that allows the company to sell up to 63 shares of Series D Preferred Stock for up to $60,000. At the initial closing on September 18, 2025, GHS purchased 19 shares of Series D Preferred Stock, including three shares for legal fees, and received an additional six commitment shares.

At each closing, GHS also receives warrants equal to 50% of the common shares issuable upon conversion of the purchased Series D Preferred Stock. At the initial closing, the company issued warrants to purchase up to 71,250,000 common shares at $0.000345 per share, exercisable until September 18, 2030. Separately, the company approved a 12‑month consulting agreement with Redhawk Investment Group that includes a $140,000 retainer and additional fees totaling $360,000, payable in cash or preferred stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Gold River Prod (GRPS)?

The current stock price of Gold River Prod (GRPS) is $0.0002 as of March 2, 2026.

What is the market cap of Gold River Prod (GRPS)?

The market cap of Gold River Prod (GRPS) is approximately 549.7K.

GRPS Rankings

GRPS Stock Data

549.66k
1.24B
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Dallas

GRPS RSS Feed